Skip to main content
. 2022 Jan 19;11(3):504. doi: 10.3390/jcm11030504

Figure 3.

Figure 3

Increase of overall survival of children with AML and HSCT in CR1 (any donor/conditioning) since 1981; 10 year-periods (AML-BFM trials).